Reproducibility of the mfERG between instruments by Harrison, Wendy W. et al.
ORIGINAL RESEARCH ARTICLE
Reproducibility of the mfERG between instruments
Wendy W. Harrison Æ Marcus A. Bearse Jr. Æ
Jason S. Ng Æ Shirin Barez Æ Marilyn E. Schneck Æ
Anthony J. Adams
Received: 15 August 2008/Accepted: 3 March 2009/Published online: 26 March 2009
 The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract Purpose First, to examine both the repro-
ducibilityofthe multifocalelectroretinogram (mfERG)
recorded on different versions of the same instrument,
and the repeatability of the mfERG recorded on a
single instrument using two different ampliﬁers.
Second, to demonstrate a means by which multicenter
and longitudinal studies that use more than one
recording instrument can compare and combine data
effectively. Methods Three different ampliﬁers and
two mfERG setups, one using VERIS
TM 4.3 software
(mfERG1) and another using VERIS
TM Pro 5.2
software (mfERG2), were evaluated. A total of 73
subjectswithnormalvisionweretestedinthreegroups.
Group1(n = 42)wasrecordedusingtwoampliﬁersin
parallel on mfERG1. Group 2 (n = 52) was recorded
on mfERG2 using a single ampliﬁer. Group 3 was a
subgroup of 21 subjects from groups 1 and 2 that were
testedsequentiallyonbothinstruments.Afourthgroup
of 26 subjects with diabetes were also recorded using
the two parallel ampliﬁers on mfERG1. P1 implicit
times andN1-P1amplitudesofthe 103 local ﬁrst order
mfERGs were measured, and the differences between
the instruments and ampliﬁers were evaluated as raw
scores and Z-scores based on normative data. Mea-
surements of individual responses and measurements
averaged over the 103 responses were analyzed.
Results Simultaneous recordings made on mfERG1
withthetwodifferentampliﬁersshoweddifferencesin
implicit times but similar amplitudes. There was a
mean implicit time difference of 2.5 ms between the
ampliﬁers but conversion to Z-scores improved their
agreement.Recordingsmadeondifferentdayswiththe
two instruments produced similar but more variable
results, with amplitudes differing between them more
than implicit times. For local response implicit times,
the 95% conﬁdence interval of the difference between
instruments was approximately ±1 Z-score (±0.9 ms)
ineitherdirection.Forlocalresponseamplitude,itwas
approximately ±1.6 Z-scores (±0.3 lV). Conclusions
Different ampliﬁers can yield quite different mfERG
P1 implicit times, even with identical band-pass
settings. However, the reproducibility of mfERG
Z-scores across recording instrumentation is relatively
high. Comparison of data across systems and labora-
tories, necessary for multicenter or longitudinal
investigations, is facilitated if raw data are converted
into Z-scores based on normative data.
Keywords Multifocal electroretinogram 
Reproducibility  VERIS
TM instruments 
Repeatability
W. W. Harrison (&)  M. A. Bearse Jr. 
J. S. Ng  S. Barez  M. E. Schneck  A. J. Adams
University of California Berkeley School of Optometry,
Vision Science Program, 360 Minor Hall, Berkeley,
CA 94720-2020, USA
e-mail: wwh@berkeley.edu
J. S. Ng
Department of Basic and Visual Science, Southern
California College of Optometry, 2575 Yorba Linda
Blvd., Fullerton, CA 92831, USA
123
Doc Ophthalmol (2009) 119:67–78
DOI 10.1007/s10633-009-9171-zIntroduction
The multifocal electroretinogram (mfERG) is a non-
invasive objective technique that simultaneously
measures retinal function at multiple retinal locations.
It is used for the evaluation of retinal neuronal
populations, as well as for the prediction and assess-
ment of a wide variety of retinal diseases, including
retinitis pigmentosa, diabetic retinopathy, and age-
related macular degeneration [1–6]. The mfERG is
also used for the evaluation of drug toxicity and
surgical success [7–10], and its uses continue to
expand in both the clinical and research arenas.
Although limited in number, previous studies have
examined the repeatability of the mfERG and found it
to be high with variations across systems [3, 11–15].
These studies have reported implicit time coefﬁcients
of variation (CV) as low as 3.1% (when achieving
good repeatability was a goal of the study), and as
high as 30.3% (when factors inﬂuencing variations in
the mfERG were not fully controlled) [12, 15]. The
CVs for amplitudes have been reported to range from
10.4% to 36% [13, 15]. Most studies have found that
averaging over larger retinal areas reduces variability,
and have consequently reported the CVs of rings of
responses. Given all of the potential sources of
variability that exist in an mfERG recording session,
both intrinsic to the subjects and in the stimulus
conditions and equipment, the high repeatability from
these past studies is encouraging as long as the testing
environment is controlled. ISCEV guidelines for
clinical mfERG recording [16] are in place to help
achieve uniformity in testing situations.
While the ISCEV guidelines specify that each
clinic or laboratory establish their own norms, they
do not address how clinics or laboratories could pool
data for multicenter investigations. These may be
necessary in the future to improve the statistical
power of mfERG studies in the presence of relatively
small samples. In addition, malfunction or aging of
the mfERG equipment being used in a clinic or
laboratory can require replacing components, causing
inconsistency in the data being collected. This is
especially important if follow-up data are to be
interpreted or in longitudinal studies over a number
of years. Scientists and clinicians are faced with
the dilemma of replacing aging equipment while
attempting to reduce inconsistencies in data collec-
tion and interpretation.
Reproducibility of the mfERG across instruments
has not previously been examined. The purpose of
this study is to evaluate the robustness and stability of
the mfERG as it is recorded over both time and with
different instrumentation (in the case of this study,
different VERIS
TM instruments and ampliﬁers). Our
results show that the reproducibility of the mfERG
across recording instrumentation is quite high and
that converting raw data into Z-scores based on
normative data facilitates meaningful comparison
of results across recording systems and different
laboratories.
Methods
Systems and stimulus characteristics
Two visual evoked response imaging systems (VE-
RIS
TM) (EDI, Redwood City, CA) were used to
record ﬁrst-order mfERGs. Both systems stimulated
using luminance modulation of a 458, 103-element
hexagonal array scaled with eccentricity. The stim-
ulus background, bright ﬂashes, and dark elements
were set to 100 cd/m
2, 200 cd/m
2, and \2 cd/m
2
(99% contrast), respectively. In addition, the ambient
room lighting was between 80 and 100 cd/m
2 on the
wall behind each instrument. Both systems had a
75 Hz frame rate monochrome CRT monitor display
and ran a standard m-sequence (2
15–1) that lasted
approximately 8 min. Each recording session was
broken into 16 segments, approximately 30 s each,
and the retinal signals were band-pass ﬁltered at
10–100 Hz and sampled every 0.83 ms.
However, some features were different between the
two recording setups (Table 1). Features unique to the
ﬁrst system (mfERG1) include that it runs VERIS
TM
Table 1 Differences between mfERG instruments
Characteristics mfERG1 mfERG2
Veris software VERIS
TM 4.3 VERIS
TM Pro
5.2
Ampliﬁer model(s) CP511 and
P511
LT15
Ampliﬁer setting 100,000 50,000
Monitor display and screen
resolution
CRT 75 Hz CRT 75 Hz
1024 9 768
pixels
640 9 480
pixels
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1234.3 software and has a stimulus screen resolution of
1024 9 768. It also has two external Grass Telefactor
(Astro-Med Inc, West Warwick, RI) ampliﬁers. The
ﬁrst ampliﬁer (‘‘mfERG1 New Amp’’; recording
channel 1; Grass model CP511) was produced in
1996. The second ampliﬁer (‘‘mfERG1 Old Amp’’;
recording channel 2; Grass model P511) was manu-
factured in 1983. Both ampliﬁers on mfERG1 were set
to amplify 100,000 times. Features unique to the
second system (mfERG2) include that it runs VE-
RIS
TM Pro 5.2 software, has a stimulus screen
resolution of 640 9 480, and has one computer-
controlled Grass ampliﬁer (‘‘mfERG2 Amp’’; Grass
model 15LT), which was produced in 2006 and set to
a gain of 50,000.
Comparison of the frequency response curves of
the ampliﬁers, as speciﬁed by Grass, showed that the
two newer ampliﬁers (mfERG1 New Amp and
mfERG2 Amp) should have similar band-pass ﬁlter-
ing characteristics but that the older ampliﬁer
(mfERG1 Old Amp) is slightly different. The differ-
ence between the ampliﬁers of mfERG1 was veriﬁed
by inputting sine waves of varying frequencies but
ﬁxed amplitude and measuring the output amplitudes
with the ﬁlters set at 10–100 Hz (Fig. 1). In addition,
an artiﬁcial eye comprising a photodiode and an R–C
circuit was run on both instruments and all three
ampliﬁers to further characterize the implicit time
differences inherent between them. The peak laten-
cies of the ﬁrst order ‘‘mfERGs’’ recorded from
the artiﬁcial eye were consistently 2.5 ms shorter for
the older (mfERG1, channel 2) ampliﬁer than for the
other two ampliﬁers.
Subjects and recordings
Seventy-three subjects with normal vision and 26
subjects with diabetes were included in this study.
Patient demographic information is given in Table 2.
The subjects were divided into four groups. Group 1
comprised 42 subjects with normal vision recorded
simultaneously (in parallel) on both ampliﬁers of
mfERG1. Group 2 comprised 52 subjects with normal
visionrecordedonmfERG2.Withingroup2,9ofthese
subjectsreturned forfollow-up1 year later toexamine
intra-instrumentrepeatabilityovertime.Group3wasa
subset of the ﬁrst two groups and consisted of 21
subjectswhowererunonbothinstrumentswithinatwo
monthperiod(mean = 0.94 ± 0.68 months).Group4
was composed of 26 subjects with diabetes without
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Fig. 1 The measured
ﬁltering characteristics of
the new (D) and old (j)
ampliﬁers on mfERG1
when set at 10–100 Hz
Table 2 Subject
demographic information
Subject group mfERG instrument Number of subjects Age ± SD
Group 1 mfERG1: both ampliﬁers 42 with normal vision 45.2 ± 12.75
Group 2 mfERG2 52 with normal vision 43.7 ± 14.5
Group 3 (subgroup
of groups 1 and 2)
mfERG1 and mfERG2 21 with normal vision 47.4 ± 13.6
Group 4 mfERG1 26 with diabetes 51.3 ± 11.9
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123retinopathy, recorded on the two parallel channels of
mfERG1.
MfERGs were recorded from one eye while the
other eye was occluded. Pupils were fully dilated to
at least 7 mm with 1% tropicamide and 2.5% phenyl-
ephrine, and 0.5% proparacaine was used to anesthe-
tize the cornea prior to recording. A Burian-Allen
bipolar contact lens electrode ﬁlled with 1.0%
carboxymethlcellulose sodium solution was used for
all mfERG recordings. Each instrument was used
with its own dedicated contact lens electrode. A clip
ground electrode was applied to the subject’s earlobe
and the resistance between the electrode leads was
measured and kept under 10 k-Ohms. Both systems
had in-line video cameras that allowed for real-time
observation of the eye during testing. Recording
segments contaminated by signal saturation or loss of
ﬁxation were discarded and repeated. All subjects had
20/20 (logMAR 0.0) or better visual acuity and were
free of retinal disease and media opacities, as
evaluated by ophthalmic examination and masked
retinal photograph grading. All subjects had refrac-
tive errors between -6D and ?4D. The study
adhered to the Declaration of Helsinki and was
approved by the Committee for the Protection of
Human Subjects at the University of California
Berkeley. Written informed consent was obtained
from all subjects after the study was fully explained
at their ﬁrst visit.
Waveform and data analysis
The ﬁrst-order mfERG kernel was analyzed. A single
iteration of artifact removal was used on both
instruments with 17% spatial averaging. The 103
mfERGs were exported and the Hood and Li template
scaling method was applied to all waveforms to
derive P1 implicit time and N1-P1 amplitude [17].
This method minimizes the least squares difference
between a waveform and the local template. The
template represents the mean local waveform of the
subjects with normal vision and it is independently
scaled in both amplitude and time to ﬁt the individual
local responses. The scaling factors are then used to
derive implicit time and amplitude. The templates
were created from the data of all subjects with normal
vision in a group and a different set of 103 local
response templates was used for each of the three
ampliﬁers. Group 4’s data was analyzed using the
appropriate template from group 1. Implicit times and
amplitudes were evaluated for all subjects as both
raw scores and Z-scores, where the mean and
standard deviation were calculated from all subjects
with normal vision available for that ampliﬁer-
instrument combination after determining that the
normative data for each of the 103 hexagons did not
differ from a normal distribution (chi-square tests;
mean P = 0.58 ± 0.25). Responses were analyzed as
whole eye averages (103 response measures aver-
aged together) and also as individual local mfERG
measurements.
Results
Ampliﬁer comparisons on the same mfERG
instrument
Recordings from the 2 ampliﬁers of mfERG1 using
the two parallel channels were made from the subjects
in groups 1 and 4. As the two recordings were made
simultaneously, any differences between them can be
attributed to the ampliﬁers (potential differences in
gain, ﬁltering, and noise), and no other sources of
variation existed. The raw measurements of the 103
local mfERGs were ﬁrst examined and then they were
converted to Z-scores. The 103 raw measurements
were then averaged to give one value for each subject.
The Z-scores were similarly averaged.
The N1-P1 amplitudes were very similar with a
mean difference of 0.01 ± 0.003 lV, and a maxi-
mum difference of 0.013 lV (6.5% of the mean
value) between ampliﬁers for the whole eye average
of any individual subject (data not shown). This was
expected since the ampliﬁers were calibrated to
provide similar overall gains. The mean amplitudes
for the two channels were also similar for individual
hexagons (0.21 ± 0.05 lV and 0.20 ± 0.05 lV for
the ﬁrst and second channels, respectively). Figure 2a
shows the whole eye raw amplitude data obtained
with both ampliﬁers from the subjects with normal
vision (group1) and subjects with diabetes (group 4).
Figure 2b shows the Z-scores of these same subjects.
Figure 2b illustrates how the small difference
between the ampliﬁers decreased after the conversion
to Z-scores, and the data for both groups fall along a
diagonal with a slope of 1.
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123Figure 2c shows the raw implicit time data
obtained from both ampliﬁers. The mean implicit
time difference between the two ampliﬁers was
2.5 ms. Figure 2d shows the Z-scores of the diabetic
subjects and the subjects with normal vision with the
data falling on a diagonal (slope = 1) passing
through the origin. The implicit times showed a
better agreement after the conversion to Z-scores.
Local response implicit time differences between
the ampliﬁers were examined for subjects with
diabetes. The 2.5 ms mean difference in implicit
times between the two ampliﬁers also occurred
locally, but with conversion to Z-scores, the ampliﬁers
had good local agreement for all simultaneous
recordings. Past studies in our lab have used implicit
time Z-scores C2.0 (P B 0.023) as indications of
abnormality [3, 18]. Table 3 shows that by applying
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Fig. 2 mfERG1 ampliﬁer raw data and Z-score comparison
for amplitude and implicit time. a Raw amplitude data; b
Amplitude Z-score data; c Raw Implicit Time data and d Z-
score Implicit Time data. Each data point indicates a whole eye
average for one subject. Subjects with normal vision, Group 1
(Control) (m), and subjects with diabetes, Group 4 (X), are
plotted together
Table 3 Local ampliﬁer agreement for subjects with diabetes
(95.6%)
New Amp
[2 Z
New Amp
\2 Z
Total
Old Amp[2 Z 401 (15.0%) 53 (2.0%) 454 (17%)
Old Amp\2 Z 63 (2.4%) 2161 (80.6%) 2224 (83%)
Total 464 (17.4%) 2214 (82.6%) 2678 (100%)
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123this criterion to the local data from the subjects with
diabetes in this study, the two ampliﬁers had 95.6%
agreement when classifying a local mfERG implicit
time as normal or abnormal. A similar analysis was
done for the subjects with normal vision using a
criterion of 1.0 Z-score, also producing a high
agreement of 92.5% (data not shown).
Reproducibility between different instruments
This section presents the comparison of mfERG data
collected on different days using different instru-
ments. Figure 3 shows the results for whole-eye
average comparisons between the older ampliﬁer
(Grass model P511) of the mfERG1 system and
mfERG2 system (Grass model 15LT ampliﬁer) for
subject group 3. The plot of the implicit times in
Fig. 3a shows that, on average, there is a 2.5 ms
difference between the two instruments, which is in
agreement with the artiﬁcial eye. The mean implicit
time of subjects on mfERG1 Old Amp was
28.80 ± 0.91 ms and the mean implicit time on
mfERG2 was 31.30 ± 0.87 ms. As expected, there is
a lower correlation (R
2 = 0.81) in the implicit time
data than was observed earlier in the simultaneous
recordings on a single mfERG instrument. The
implicit times obtained on the two instruments are
re-plotted as a Bland–Altman plot [19] in Fig. 3b.
The difference between the two instruments is plotted
on the y-axis and the mean of the instruments is
plotted on the x-axis for each subject. The zero slope
(95% CI =- 0.24 to 0.20) and the y-intercept of the
least squares regression indicate that there is an
implicit time offset of about 2.5 ms between them. (If
the intercept and the slope of the line were both 0, the
two instruments would be directly comparable. If the
line had a signiﬁcant slope, the instruments would not
be easily comparable.) By converting the implicit
times into Z-scores, the two instruments are now
more comparable (Fig. 3c). The 95% conﬁdence
interval of ±0.86 Z-scores indicates that implicit time
Z-scores are highly reproducible on the two instru-
ments. The differences between the two instruments
ranged from 0.06 to 1.03 Z-scores.
Figure 4a shows the whole eye average amplitude
comparison for the 21 subjects in group 3 for the
older ampliﬁer of mfERG1 and for mfERG2. The
mean amplitude of mfERG2 was 0.30 ± 0.07 lV
compared to 0.20 ± 0.05 lV for mfERG1 Old Amp.
Although the agreement of amplitudes between the
instruments varies among the subjects (R
2 = 0.43),
the two instruments are comparable as the 95%
conﬁdence interval of the slope of the regression line
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Fig. 3 Implicit time comparison for the older ampliﬁer of
mfERG1andmfERG2.aComparisonoftheimplicittimes(ms).
Each pointisawholeeyeaverageofonesubjectfromgroup3;b
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theplotindicate the95% conﬁdenceinterval andthesolidlineis
the mean difference (2.5 ms for the range of the mean implicit
time data observed) between the instruments for all 21 subjects.
The slope of the line is not statistically different from zero
(P = 0.88); c The Bland–Altman plot of the Z-scores of the
implicit time data with the dashed lines indicating the 95%
conﬁdence interval and the solid line indicating the mean
difference (0.05 Z-score units) for the 21 subjects. The slope of
this line is not different from zero (P = 0.92)
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123contains 1.0 (95% CI = 0.32–1.11). The Bland–
Altman plot of the amplitude data (Fig. 4b) shows
an average difference of 0.07 lV across all values but
with a large 95% conﬁdence interval associated with
this value (0.01 to -0.19 lV). The Z-score Bland–
Altman plot (Fig. 4c) also has a slope that is not
signiﬁcantly different from zero (P = 0.29) and the
fact that the regression line passes through zero
shows that the data is in better agreement with this
conversion. The range of amplitude differences for
these 21 subjects was large ranging from 0.1 to 1.6
Z-scores. The 95% conﬁdence interval of ±1.5
Z-scores indicates that amplitude is not as reproduc-
ible as implicit time.
Data collected on the newer ampliﬁer of mfERG1
(Grass model CP511) was also compared to data
collected on mfERG2. As expected from their similar
band-pass ﬁltering characteristics, these two ampliﬁ-
ers exhibited raw implicit times that were similar
(Fig. 5a), with a mean difference of only 0.1 ±
0.34 ms between the two instruments (Fig. 5b). The
mean implicit time for mfERG1 New Amp was
31.40 ± 0.90 ms and the mean implicit time for
mfERG2 was 31.30 ± 0.87 ms. Conversion of the
data into implicit time Z-scores produced an even
smaller mean difference between the instruments,
making them more comparable (Fig. 5c). The 95%
conﬁdence interval of the difference between the two
similar ampliﬁers was ±0.74 Z-scores.
The mfERG recordings performed to compare the
instruments were not obtained in the same session,
and so the question arises as to how much of the
observed difference is due to subject variation over
time and how much is due to actual instrumentation
and electrode differences. To address this, 9 subjects
with normal vision were recorded on mfERG2 and
retested 1 year later (±15 days). The results showed
that the mean (of all 103 local response measure-
ments) implicit time Z-scores differed from 0.04 to
0.76 Z-scores with a mean difference of 0.36 ± 0.28
Z-scores. The amplitude Z-score differences ranged
from 0.02 to 2.60 Z-scores, with a mean difference of
0.85 ± 0.81 Z-scores. For these 9 subjects, coefﬁ-
cients of variation (CV) were also calculated for the
raw data of each of the 103 hexagons for both
implicit time and amplitude. The local implicit time
CVs ranged from 2.2% to 4.3% with a whole eye
average of 3.0 ± 0.5%. The local amplitude CVs
ranged from 10.5% to 47.3% with a whole eye
average of 23.7 ± 6.9% (data not shown). This
indicates that implicit time remains fairly stable over
recording sessions but amplitudes are more variable.
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123The last analysis explored the similarity of implicit
time and amplitude measures of the 103 local
mfERGs obtained on the two instruments. The 95%
conﬁdence intervals of the difference between
mfERG2 and the older ampliﬁer of mfERG1 (the
most different hardware conﬁgurations) were evalu-
ated at all 103 retinal locations for the 21 subjects in
group 3. The plots in Fig. 6 show the individual
Z-score conﬁdence intervals, represented as vertical
gray bars, and the mean conﬁdence intervals, repre-
sented as dashed horizontal lines. For implicit time,
the mean local difference between the two instru-
ments was 0.01 Z-score. The dashed horizontal lines
in Fig. 6a indicate the mean 95% conﬁdence interval
(1.07 to -1.05). The locations near the blind spot
(e.g., elements 48 and 59), are the most variable (up
to 1.5 Z-scores in each direction). Based on these
results, a local difference in implicit time must be
greater than approximately 1 Z-score unit to differ-
entiate it from inter-instrument variability and
establish a signiﬁcant functional change at a single
retinal location. In this study, all of the subjects have
normal vision (controls) and so no actual retinal
defects existed. Both instruments agreed that all of
these subjects were normal, with no subject having
more than 4 local implicit time Z-scores C2.0
(P = 0.91). Figure 6b shows the 95% conﬁdence
intervals for the difference in amplitude Z-scores for
the same responses. While the mean difference for all
of the hexagons is small (0.04 Z-scores), the local
amplitudes had more variation than the implicit
times. The average 95% conﬁdence interval for the
amplitude Z-scores was 1.63 to -1.54 with some
hexagons having a 95% conﬁdence interval [2.0
Z-scores.
Discussion
The purpose of this study was to evaluate the
robustness and stability of the mfERG as it is
recorded over both time and with different instru-
mentation from the same manufacturer. In this study,
we used VERIS
TM software and hardware. Although
there have been several studies examining the
repeatability and variability of the mfERG, the
reproducibility of the mfERG across systems within
a laboratory or across laboratories had not been
examined. Understanding this reproducibility is a key
component in pooling and comparing data across
laboratories and replacing all or parts of an mfERG
instrument during a study. For multicenter mfERG
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123studies, the reproducibility, or agreement, of the
response measures must be established ﬁrst.
It is known from past studies that there are many
sources of possible variation in the mfERG. It has
been shown that differences in luminance [20],
contrast [21], pupil size [22], adaptation states [23,
24], and even less than full correction of refractive
error [25, 26] can all cause alterations in the mfERG.
Furthermore, the way the data are ﬁltered and
processed during the recording session is another
potential source of variability from session to session
and laboratory to laboratory [27, 28]. These past
studies have shown that while there are many factors
that can cause variability, if they are controlled
within a laboratory, the repeatability of the mfERG
responses can be good, particularly with implicit time
measures. All of these factors were controlled in this
study in both intra-session and inter-session record-
ings. Furthermore, the use of the Hood and Li
template scaling method in this study may have
helped to improve reproducibility. Compared to
measurements of peaks and troughs made manually,
the template scaling method is more objective and
less affected by noise. The method’s relative insen-
sitivity to noise is due to the fact that the waveform
template is ﬁt to the response being measured, using a
least-squares criterion, over an 80 ms epoch. Thus,
random noise in the region of the P1 peak has
relatively little effect on either its estimated ampli-
tude or implicit time.
Overall, we found the mfERG Z-scores for ampli-
tude were satisfactorily reproducible and Z-scores for
implicit time were very reproducible across time and
with different instrumentation. The ± 0.86 Z-score
conﬁdence interval for mean implicit time corre-
sponds to ± 0.73 ms, which is less than ± 1 real-
time signal sample in our recordings. However,
differences in recording instrumentation can cause
raw response measures to be very different between
instruments. These raw response differences can exist
even when systems are similarly calibrated and when
band-pass ﬁlter settings are nominally the same. In
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123our study, the ampliﬁers on mfERG1 were set to the
same band-pass settings and records were taken
simultaneously; the raw amplitudes were similar but
raw implicit times were very different (2.5 ms mean
difference) in the two channels. These implicit time
differences are not surprising, given the different
ﬁlter characteristics, but it must be noted that 2.5 ms
is a large difference, more than 2.0 Z-scores. This
difference is large enough to cause concern in a
longitudinal study or comparison of data across
laboratories, if one were not aware of the ﬁltering
differences between ampliﬁers. This difference could
also lead to a belief that an eye had improved or
deteriorated even when there was no actual change.
By normalizing, using data from a normal popula-
tion, mfERG measurements are more comparable and
in reasonably close agreement across instruments, and
the effects of differences in instrumentation are
minimized. The normal subject samples should be
similar and matched appropriately to the disease state
andpatientsamplebeingstudied,aswasthecaseinthis
study. There are multiple normalization methods,
including percentiles and Z-scores. We chose Z-scores
for a number of reasons. They include the mean and
variability of the normative data and so they can be
quickly used to identify abnormalities. However, most
importantly, they transform the measurements so that
theyarerelativetothecontroldatacollectedonspeciﬁc
instruments.Anotherpossibleapproachtomakingdata
more comparable is to band-pass ﬁlter recordings over
a larger frequency range and then digitally ﬁlter the
responses. This would likely remove some of the
differences we observed in implicit time. Since digital
ﬁlteringusesFourieranalysis,thereisnophaseshiftas
there can be in analog ﬁltering. However, digital
ﬁltering would likely not help in making amplitude
data more reproducible.
For the ﬁrst part of our study, we performed
ampliﬁer comparisons using parallel channels. We
did this to avoid time-varying (test–retest) factors and
to isolate differences in the instrumentation. When
comparing both the same and different instruments
across time in the second part of our study, we found
that amplitudes were much less repeatable than
implicit times. This is in agreement with earlier
studies, which have also found amplitudes to be more
variable [29]. The CVs we found for both amplitudes
and implicit times are in agreement with previous
studies [12, 13, 15] when averaging over the whole
eye. We also looked at CVs on a local level and
found them to be fairly consistent across the retina
when examining implicit time but highly variable for
amplitudes. No CVs were calculated for Z-score data
as CVs are poor estimates of variation when the mean
of the data is near zero, which is the case for Z-scores
of subjects with normal vision. However, the range of
Z-score differences in amplitude measurements are
also much more variable than it is for implicit times.
In general, comparison of different instruments
involves true instrument differences (e.g., the hard-
ware and software design) and test–retest variation. It
appears that a large part of the variability between
instruments that we observed, especially in ampli-
tude, might come from inter-session rather then inter-
instrument sources. Most of the response variation we
observed between the instruments, after conversion to
Z-scores, was of the same magnitude as test–retest on
the same instrument with the same ampliﬁer. There-
fore, it appears that data collected on different setups
can be compared more easily after conversion to
Z-scores, at least when recording conditions are
sufﬁciently equated.
Previous studies examining the repeatability of the
mfERG have typically used ring averages to look at
the differences between different sessions. This study
uses comparisons among eye averages and also
among local response measurements. In agreement
with other studies [12, 13], we found, not surpris-
ingly, that the local measures are less repeatable in
comparison to whole eye averages. There are a
number of reasons why local measurements can be
less repeatable than eye averages, including a lower
signal to noise ratio, small changes in stimulus
placement on the retina, and changes in electrode
placement in the case of amplitudes.
In conclusion, the mfERG is quite reproducible,
even across different recording installations. This
study suggests that it is possible to compare and/or
combine data obtained from different instrumenta-
tion, provided that sufﬁciently large and similar
normative data sets are collected on each instrument.
Conversion of raw mfERG measurements to Z-scores
based on normative data is an efﬁcient and effec-
tive means to compare or combine measurements
obtained with different instrumentation. Such com-
parisons and combinations are critical to multicenter
studies, some longitudinal studies, and to following
patients over years of care.
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